Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Jakarta - Delayed Quote IDR

PT Charlie Hospital Semarang Tbk (RSCH.JK)

Compare
384.00
+2.00
+(0.52%)
At close: April 11 at 4:10:46 PM GMT+7
Loading Chart for RSCH.JK
  • Previous Close 382.00
  • Open 380.00
  • Bid 384.00 x --
  • Ask 386.00 x --
  • Day's Range 372.00 - 388.00
  • 52 Week Range 170.00 - 410.00
  • Volume 1,057,000
  • Avg. Volume 1,848,552
  • Market Cap (intraday) 1.018T
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia. It offers medical services and support, inpatient, and medical check-up services, as well as operates wellness center. The company was founded in 2019 and is based in Kendal, Indonesia. PT Charlie Hospital Semarang Tbk is a subsidiary of PT Wahyu Agung.

charliehospital.co.id

214

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RSCH.JK

View More

Performance Overview: RSCH.JK

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

RSCH.JK
28.86%
IDX COMPOSITE (^JKSE)
11.55%

1-Year Return

RSCH.JK
90.10%
IDX COMPOSITE (^JKSE)
14.06%

3-Year Return

RSCH.JK
164.83%
IDX COMPOSITE (^JKSE)
13.07%

5-Year Return

RSCH.JK
164.83%
IDX COMPOSITE (^JKSE)
34.70%

Compare To: RSCH.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RSCH.JK

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    1.02T

  • Enterprise Value

    1.02T

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.24%

  • Return on Assets (ttm)

    -1.10%

  • Return on Equity (ttm)

    -2.36%

  • Revenue (ttm)

    48.5B

  • Net Income Avi to Common (ttm)

    -3.51B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.81B

  • Total Debt/Equity (mrq)

    27.31%

  • Levered Free Cash Flow (ttm)

    -39.09B

Research Analysis: RSCH.JK

View More

Company Insights: RSCH.JK

Research Reports: RSCH.JK

View More

People Also Watch